
<rss version="2.0">
  <channel>
    <title>Y! Health Cholesterol News</title>
    <link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/</link>
    <description>Y! Health Cholesterol News, updated continuously.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Nov 2009 10:02:16 PST</lastBuildDate>
    <copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright>
    <ttl>5</ttl>
    <image>
      <title>Yahoo! Health</title>
      <width>142</width>
      <height>18</height>
      <link>http://health.yahoo.com/</link>
      <url>http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif</url>
    </image><item><title>Cholesterol Plays Role in Heart Failure Risk (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/cholesterolplaysroleinheartfailurerisk.html</link><guid isPermaLink="false">yahoo/health/news/healthday/cholesterolplaysroleinheartfailurerisk</guid><pubDate>Tue, 24 Nov 2009 20:48:30 PST</pubDate><description>HealthDay - TUESDAY, Nov. 24 (HealthDay News) -- Abnormal cholesterol levels 
can significantly increase the risk of heart failure, a new study has 
found.</description></item><item><title>Selenium supplementation may boost cholesterol (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_selenium_supplementation.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_selenium_supplementation</guid><pubDate>Tue, 24 Nov 2009 07:42:39 PST</pubDate><description>Reuters - Taking too much selenium, an essential mineral touted for immune boosting and anti-cancer benefits, could increase cholesterol levels by 10 percent and, as a result, raise the risk of heart disease, a new study suggests.</description></item><item><title>Incidence of High Cholesterol Drops in U.S. (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/incidenceofhighcholesteroldropsinus.html</link><guid isPermaLink="false">yahoo/health/news/healthday/incidenceofhighcholesteroldropsinus</guid><pubDate>Tue, 17 Nov 2009 20:48:55 PST</pubDate><description>HealthDay - TUESDAY, Nov. 17 (HealthDay News) -- The good news is that a new 
report shows the percentage of American adults with high LDL cholesterol, 
the &quot;bad&quot; kind that clogs arteries, decreased by about one-third between 
1999 and 2006.</description></item><item><title>High cholesterol under treated in many Americans (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_high_cholesterol.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_high_cholesterol</guid><pubDate>Tue, 17 Nov 2009 13:37:47 PST</pubDate><description>Reuters - A US study on cholesterol released today contains both good and bad news:</description></item><item><title>Crestor shows equal or better benefit to women (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_heart_astrazeneca_women.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_heart_astrazeneca_women</guid><pubDate>Tue, 17 Nov 2009 13:16:06 PST</pubDate><description>Reuters - A fresh look at data from a landmark study showed that AstraZeneca's powerful cholesterol fighter Crestor dramatically cut deaths, heart attacks and strokes in women at least as much as in men, providing new evidence of the drug's benefits in a previously understudied population.</description></item><item><title>Many in U.S. still lack cholesterol tests, drugs (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_cholesterol_screening.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_cholesterol_screening</guid><pubDate>Tue, 17 Nov 2009 13:14:19 PST</pubDate><description>Reuters - Many people in the United States are still not being screened for high levels of so-called bad cholesterol, and when they are found to have it, are often never treated, U.S. researchers said on Tuesday.</description></item><item><title>Benefit of Merck heart drug remains after stopping (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_heart_merck_cetp.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_heart_merck_cetp</guid><pubDate>Tue, 17 Nov 2009 12:00:13 PST</pubDate><description>Reuters - High doses of an experimental heart medicine being developed by Merck &amp; Co MRK.N continued to show beneficial effects on both good HDL and bad LDL cholesterol levels eight weeks after patients stopped taking the drug, in a mid-stage study.</description></item><item><title>Isis cholesterol drug meets all goals of key trial (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_heart_isis.html</link><guid isPermaLink="false">yahoo/health/news/reuters/us_heart_isis</guid><pubDate>Tue, 17 Nov 2009 06:32:41 PST</pubDate><description>Reuters - An experimental drug for patients genetically disposed to extreme high cholesterol being developed by Isis Pharmaceuticals Inc and Genzyme Corp significantly lowered cholesterol in a pivotal late-stage study, according to data presented on Tuesday.</description></item><item><title>Study Raises New Questions About Cholesterol Drug Zetia (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/studyraisesnewquestionsaboutcholesteroldrugzetia.html</link><guid isPermaLink="false">yahoo/health/news/healthday/studyraisesnewquestionsaboutcholesteroldrugzetia</guid><pubDate>Mon, 16 Nov 2009 20:49:19 PST</pubDate><description>HealthDay - SUNDAY, Nov. 15 (HealthDay News) -- A new study raises more 
questions about ezetimibe (Zetia), a drug used by millions of Americans in 
tandem with statins to lower LDL, or &quot;bad,&quot; cholesterol.</description></item><item><title>More doubts over Merck anti-cholesterol drug: study (AFP)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/afp/healthdrugsmerck_20091116213544.html</link><guid isPermaLink="false">yahoo/health/news/afp/healthdrugsmerck_20091116213544</guid><pubDate>Mon, 16 Nov 2009 13:35:07 PST</pubDate><description>AFP - A new study has cast fresh doubt on the effectiveness of Zetia, a cholesterol drug produced by US pharmaceuticals giant Merck.</description></item>  </channel>
</rss>
<!-- health:health-us:0:Success -->
<!-- fe5.health.re1.yahoo.com uncompressed/chunked Wed Nov 25 15:41:49 PST 2009 -->
